We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sinopharm’s COVID-19 Vaccine Generates ‘Comparable’ Antibodies in Trials
The item has been added to your shopping cart.
Sinopharm’s COVID-19 Vaccine Generates ‘Comparable’ Antibodies in Trials
Sinopharm’s COVID-19 vaccine generated antibodies at levels on par with some of its competitors, according to early trial data released by scientists connected with the company and other China-based research institutes.